Neoadjuvant Therapy for Resectable Pancreatic Cancer-Reference-Cited by-同舟云学术

Neoadjuvant Therapy for Resectable Pancreatic Cancer

Published:2021-07-29 Issue:5 Volume:274 Page:713-720
ISSN:0003-4932
Container-title:Annals of Surgery
language:en
Short-container-title:

Author:

Birrer Dominique L.,Golcher Henriette,Casadei Riccardo,Haile Sarah R.,Fritsch Ralph,Hussung Saskia,Brunner Thomas B.,Fietkau Rainer,Meyer Thomas,Grützmann Robert,Merkel Susanne,Ricci Claudio,Ingaldi Carlo,Di Marco Mariacristina,Guido Alessandra,Serra Carla,Minni Francesco,Pestalozzi Bernhard,Petrowsky Henrik,DeOliveira Michelle,Bechstein Wolf O.,Bruns Christiane J.,Oberkofler Christian E.,Puhan Milo,Lesurtel Mickaël,Heinrich Stefan,Clavien Pierre-Alain

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Surgery

Reference57 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J Clin,2018

2. Cancer statistics, 2003;Jemal;CA Cancer J Clin,2003

3. Cancer statistics, 2019;Siegel;CA Cancer J Clin,2019

4. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer;Neoptolemos;N Engl J Med,2004

5. Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial;Regine;JAMA,2008

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Relationship between Treatment Response and Overall Survival in Borderline, Non-Resectable and Resectable Pancreatic Cancer Patients Treated with Neoadjuvant FOLFIRINOX;Journal of Clinical Medicine;2024-09-02

2. Ultrasound and diffuse optical tomography-transformer model for assessing pathological complete response to neoadjuvant chemotherapy in breast cancer;Journal of Biomedical Optics;2024-07-24

3. Guidelines for holistic integrative management of pancreatic cancer;Holistic Integrative Oncology;2024-07-08

4. Preoperative Prediction of Long-Term Survival After Surgery in Patients with Resectable Pancreatic Ductal Adenocarcinoma;Annals of Surgical Oncology;2024-06-26

5. Neoadjuvant and adjuvant systemic therapy in HCC: Current status and the future;Hepatology Communications;2024-06